Axel Cangas/LinkedIn
Jul 19, 2026, 16:58
Axel Cangas: Exploring the Future of Hemophilia Care at ISTH 2026
Axel Cangas, Hematology and Immunology Unit Head at Roche México, shared a post on LinkedIn:
”Thrilled to be at International Society on Thrombosis and Haemostasis (ISTH) 2026 engaging with global experts on the incredible scientific advancements redefining haemophilia care.
It has been inspiring to see Roche’s deep, long-term commitment to this community.
We remain dedicated to standing alongside patients, families, and healthcare professionals for generations to come.”
Stay updated with Hemostasis Today.
-
Jul 21, 2026, 01:28Dhamirah Nazihah Mohd Nasiruddin: A Milestone in My Haemostasis and Thrombosis Journey at ISTH 2026
-
Jul 21, 2026, 00:55Anita Brikman on PPTA’s First-Half 2026 Achievements
-
Jul 21, 2026, 00:50Caitlin Raymond: Can Therapeutic Plasma Exchange Reduce Microplastics?
-
Jul 21, 2026, 00:46Yohei Hisada: Science, Collaboration, and New Beginnings at ISTH 2026
-
Jul 21, 2026, 00:41Ahmed Koriesh: Inside Our 2026 Stroke Simulation Lab
-
Jul 20, 2026, 21:17Connie Montgomery: Building Community Through the HFA Black Voices Summit
-
Jul 20, 2026, 21:15Leonie Bolt: Honored to Present on Coronary Artery Calcium Scoring in Hemophilia A at ISTH 2026
-
Jul 20, 2026, 21:12Mihir Jain: Can Gene Therapy Transform Hemophilia Care in India?
-
Jul 20, 2026, 21:10Mohammed W. Badri: Are We Doing Enough to Prevent Life-Threatening Bleeds in Children?